Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet.
Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet.
复制标题
长期给予线粒体靶向肽 SS-31 可预防喂食西方饮食的 ApoE 基因敲除小鼠的动脉粥样硬化发展
DOI:
10.1371/journal.pone.0185688
复制
发表时间:
2017
期刊:
影响因子:
3.7
通讯作者:
Li K
中科院分区:
文献类型:
--
作者:
Zhang M;Zhao H;Cai J;Li H;Wu Q;Qiao T;Li K
Background Oxidative stress and inflammatory factors are deeply involved in progression of atherosclerosis. Mitochondrion-targeted peptide SS-31, selectively targeting to mitochondrial inner membrane reacting with cardiolipin, has been reported to inhibit ROS generation and mitigate inflammation. The present study was designed to investigate whether SS-31 could suppress the development of atherosclerosis in vivo. Methods Male ApoE-/- mice (8 weeks old) fed with Western diet were treated with normal saline or SS-31 (1 mg/kg/d or 3 mg/kg/d) through subcutaneous injection for 12 weeks. Oil Red O staining was performed to evaluate area and sizes of the plaques. DHE staining and immunohistochemical staining of 8-OHDG was performed to assess the oxidative stress. The aorta ATP contents were assessed by the ATP bioluminescence assay kit. Immunohistochemical staining of CD68 and α-SMA and Masson’s trichrome staining were performed to evaluate the composition of atherosclerotic plaque. Biochemical assays were performed to determine the protein level and activity of superoxide dismutase (SOD). The levels of CD36, LOX-1 and ABCA1 were immunohistochemically and biochemically determined to evaluate the cholesterol transport in aorta and peritoneal macrophages. Inflammatory factors, including ICAM-1, MCP-1, IL-6 and CRP in serum, were detected through ELISA. Results SS-31 administration reduced the area and sizes of western diet-induced atherosclerotic plaques and changed the composition of the plaques in ApoE-/- mice. Oxidative stress was suppressed, as evidenced by the reduced DHE stain, down-regulated 8-OHDG expression, and increased SOD activity after chronic SS-31 administration. Moreover, systemic inflammation was ameliorated as seen by decreasing serum ICAM-1, MCP-1, and IL-6 levels. Most importantly, SS-31 administration inhibited cholesterol influx by down-regulating expression of CD36 and LOX-1 to prevent lipid accumulation to further suppress the foam cell formation and atherosclerotic progression. Conclusion Administration of SS-31 prevents against atherosclerotic formation in ApoE-/- mice suggesting that SS-31 might be considered to be a potential drug to prevent atherosclerotic progression.
登录
查看更多内容
DOI:
10.1038/nri3520
发表时间:
2013-10
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
20.1
作者:
Mehta, Jawahar L.;Sanada, Nobuhito;Sawamura, Tatsuya
通讯作者:
Sawamura, Tatsuya
影响因子:
15.9
作者:
Anderson, Ethan J.;Lustig, Mary E.;Neufer, P. Darrell
通讯作者:
Neufer, P. Darrell
影响因子:
37.8
作者:
Higashi Y;Sukhanov S;Shai SY;Danchuk S;Tang R;Snarski P;Li Z;Lobelle-Rich P;Wang M;Wang D;Yu H;Korthuis R;Delafontaine P
通讯作者:
Delafontaine P
影响因子:
5
作者:
Rios-Navarro, Cesar;de Pablo, Carmen;Alvarez, Angeles
通讯作者:
Alvarez, Angeles